1
SCHOSWEEN 18 LIMITED - 2014-01-31
C/o Interpath Advisory, 4th Floor Tailors Corner, LeedsIn Administration Corporate (4 offsprings)
Person with significant control
2018-02-20 ~ 2019-07-05CIF 5 - Ownership of voting rights - More than 25% but not more than 50% → OE
2
HVIVO LIMITED - 2022-10-19
HVIVO PLC - 2020-04-01
RETROSCREEN VIROLOGY GROUP PLC - 2015-04-14
RETROSCREEN VIROLOGY GROUP LIMITED - 2012-04-25
PIMCO 2917 LIMITED - 2012-04-03
40 Bank Street, Floor 24, London, EnglandActive Corporate (3 parents, 4 offsprings)
Person with significant control
2018-07-06 ~ 2020-01-20CIF 3 - Ownership of shares – More than 25% but not more than 50% → OE
CIF 3 - Ownership of voting rights - More than 25% but not more than 50% → OE
3
REVOLYMER PLC - 2017-02-28
REVOLYMER (U.K.) PLC - 2012-07-02
Fieldfisher Riverbank House, 2 Swan Lane, London, United KingdomActive Corporate (5 parents, 2 offsprings)
Person with significant control
2017-07-24 ~ 2019-08-02CIF 6 - Ownership of shares – More than 25% but not more than 50% → OE
CIF 6 - Ownership of voting rights - More than 25% but not more than 50% → OE
4
ACCELERATED DIGITAL VENTURES LIMITED - 2023-02-23
One, Coleman Street, London, EnglandActive Corporate (5 parents, 9 offsprings)
Person with significant control
2016-11-30 ~ 2019-11-11CIF 2 - Ownership of shares – More than 25% but not more than 50% → OE
CIF 2 - Ownership of voting rights - More than 25% but not more than 50% → OE
CIF 2 - Right to appoint or remove directors → OE
5
VERNALIS LIMITED - 2020-12-03
VERNALIS PLC - 2018-10-11
BRITISH BIOTECH PLC - 2003-10-01
BRITISH BIO-TECHNOLOGY GROUP PLC - 1994-07-29
BRITISH BIO-TECHNOLOGY GROUP PLC - 1994-06-03
DOUBLEMANTA LIMITED - 1989-03-17
Suite 1, 7th Floor 50 Broadway, London, United KingdomActive Corporate (5 parents, 6 offsprings)
Person with significant control
2016-04-06 ~ 2018-10-10CIF 8 - Ownership of voting rights - More than 25% but not more than 50% → OE
6
MEREO BIOPHARMA GROUP LIMITED - 2016-06-03
4th Floor, One, Cavendish Place, London, EnglandActive Corporate (11 parents, 4 offsprings)
Person with significant control
2016-06-09 ~ 2019-10-15CIF 7 - Ownership of shares – More than 25% but not more than 50% → OE
CIF 7 - Ownership of voting rights - More than 25% but not more than 50% → OE
7
OXFORD NUTRASCIENCE LIMITED - 2011-05-19
2 Royal College Street, LondonActive Corporate (1 parent)
Equity (Company account)
-14,691 GBP2023-12-31
Person with significant control
2016-06-01 ~ 2019-10-01CIF 13 - Ownership of shares – More than 25% but not more than 50% → OE
8
MF59657 PLC - 2005-06-23
MF59657 LIMITED - 2005-06-22
Belgrave House, 39-43 Monument Hill, Weybridge, Surrey, EnglandActive Corporate (4 parents, 3 offsprings)
Person with significant control
2016-04-06 ~ 2019-10-15CIF 11 - Ownership of shares – More than 25% but not more than 50% → OE
9
RUTHERFORD HEALTH LIMITED - 2019-08-16
PROTON PARTNERS INTERNATIONAL LIMITED - 2019-08-16
10 Fleet Place, LondonLiquidation Corporate (7 parents, 7 offsprings)
Person with significant control
2016-04-06 ~ 2019-12-13CIF 4 - Ownership of voting rights - More than 25% but not more than 50% → OE
10
SPHERE MEDICAL HOLDING PLC - 2017-10-20
SPHERE MEDICAL HOLDING LIMITED - 2006-11-10
GG 105 LIMITED - 2004-01-14
15 Canada Square, LondonDissolved Corporate (6 parents, 1 offspring)
Person with significant control
2017-06-26 ~ 2019-07-08CIF 9 - Ownership of shares – More than 50% but less than 75% → OE
CIF 9 - Ownership of voting rights - More than 50% but less than 75% → OE
11
OXECO PLC - 2010-06-28
OXECO TWO PLC - 2006-10-19
Unit 3, Phoenix Court Lotherton Way, Garforth, Leeds, EnglandActive Corporate (7 parents, 1 offspring)
Person with significant control
2017-07-24 ~ 2019-10-15CIF 12 - Ownership of shares – More than 25% but not more than 50% → OE
12
XEROS TECHNOLOGY GROUP LIMITED - 2014-03-18
HAMSARD 3323 LIMITED - 2014-03-18
Unit 2, Evolution Advanced Manufacturing Park, Whittle Way, Catcliffe, Rotherham, South YorkshireActive Corporate (5 parents, 1 offspring)
Person with significant control
2017-06-26 ~ 2020-05-15CIF 10 - Ownership of shares – More than 25% but not more than 50% → OE